Search

Your search keyword '"Belohlavek, Jan"' showing total 607 results

Search Constraints

Start Over You searched for: Author "Belohlavek, Jan" Remove constraint Author: "Belohlavek, Jan"
607 results on '"Belohlavek, Jan"'

Search Results

101. Effects of Hypothermia vs Normothermia on Societal Participation and Cognitive Function at 6 Months in Survivors After Out-of-Hospital Cardiac Arrest

102. Propafenone versus Amiodarone for Supraventricular Arrhythmias in Septic Shock: A Randomised Controlled Trial

105. GEOGRAPHICAL VARIATION IN PATIENT CHARACTERISTICS AND OUTCOMES IN HFPEF

106. Supplemental Material - GEospatial aNalysis of ExtRacorporeal membrane oxygenATion in Europe (GENERATE)

107. Extracorporeal life support provision in COVID-19 patients - An international EuroELSO 2022 update survey

111. ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

112. Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial

113. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

114. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

115. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

117. Risk of in-hospital mortality identified according to the typology of patients with acute heart failure: Classification tree analysis on data from the Acute Heart Failure Database–Main registry

118. Acute coronary syndromes with ongoing myocardial ischemia (ACS with OMI) versus acute coronary syndromes without ongoing ischemia (ACS without OMI): The new classification of acute coronary syndromes should replace old classification based on ST segment elevation presence or absence—Expert consensus statement of the Czech Society of Cardiology

121. 468 Comparison of Subjects Enrolled in Large Animal Models and Human Clinical Trials Studying Post-Cardiac Arrest Interventions

124. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

125. A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt

127. Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA- HF Trial.

128. Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure : A Prespecified Analysis of the DELIVER Trial.

129. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

130. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction:the DIAMOND trial

131. Fractional Flow Reserve Versus Instantaneous Wave‐Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study

134. Extracorporeal membrane oxygenation in children with COVID-19 and PIMS-TS during the second and third wave

135. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial

136. Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure

140. Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure.

141. Abstract 11974: Impact of Routine ECPR Service on Availability of Donor Organs

143. Abstract 13076: Refractory Out-of-Hospital Cardiac Arrest in Patients With Pulmonary Embolism and Use of Extracorporeal Membrane Oxygenation: Prague OHCA Study Subanalysis

144. International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe

146. sj-pdf-2-prf-10.1177_02676591211042563 – Supplemental material for International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe

147. sj-pdf-1-prf-10.1177_02676591211042563 – Supplemental material for International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe

149. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

150. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study

Catalog

Books, media, physical & digital resources